Carleigh Zahn, DO, FACR
Ann Arbor, MI 48109
Manage Your Profile
About
Carleigh Zahn, D.O. is a Clinical Assistant Professor. She is a native Michigander who received her medical degree from Michigan State University College of Osteopathic Medicine. She completed her Internal Medicine residency at Western Michigan University Homer Stryker MD School of Medicine and her adult Rheumatology Fellowship training at the University of Iowa. Dr. Zahn was previously an Assistant Professor at the University of Toledo in their Rheumatology division and was the Associate Program Director for their Rheumatology Fellowship Program. She is invested in medical learner and patient education.
Dr. Zahn is delighted to be back in her home state, enjoying the next chapter of her career with Michigan Medicine. She is working within the Scleroderma Program, focusing on Scleroderma, including clinical trials. She also sees general rheumatology patients at her satellite clinic location.
As of January 2024, Dr. Zahn has opened the Rheumatologic Raynaud Clinic, where she serves as the Director. The clinic is housed within the Scleroderma Program and specializes in the evaluation of Raynaud's disease in relation to rheumatology, especially presentation in early rheumatologic disease. The clinic utilizes nailfold videocapillaroscopy to assist with early diagnosis and detection.
Links
Scleroderma Program linkedin
Qualifications
-
FellowshipUniversity of Iowa Hospitals and Clinics, Rhuematology, Iowa City, United States
2019 - 2021
Postdoctoral Fellowship
-
ResidencyWestern Michigan University Homer Stryker M.D. School of Medicine, Internal Medicine, Kalamazoo, United States
2016 - 2019
Residency
-
Chief ResidentWestern Michigan University Homer Stryker M.D. School of Medicine, Internal Medicine, Kalamazoo, United States
2018 - 2019
Chief Resident
-
D.O.Michigan State University College of Osteopathic Medicine, East Lansing, MI, United States
2012 - 2016
-
B.S., Human BiologyMichigan State University, East Lansing, MI, United States
2009 - 2011
-
Premedical StudiesLansing Community College, Lansing, MI, United States
2007 - 2009
Research Overview
- Scleroderma including phase 2 and phase 3 clinical trials
- rheumatologic Raynaud's include early disease detection
- patient education and improved patient outcomes
- medical education
Recent Publications
-
Romich E, Ogdie A, Shields A, Merkel P, Assassi S, Bernstein E, Bujor A, Castelino F, Chung L, Evnin L, Frech T, Gordon J, Griffith M, Hant F, Harding M, Hummers L, Khanna D, Lakin K, Lebiedz-Odrobina D, Luo Y, Makol A, Mayes M, McMahan Z, Molitor J, Moore D, Paik J, Richardson C, Skaug B, Shah A, Shah A, Steen V, VanBuren J, Volkmann E, Zahn C, Sandorfi N. Arthritis Care and Research, 2026 May 13;Journal ArticleDiscordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
-
Romich E, Ogdie A, Shields A, Merkel P, Assassi S, Bernstein E, Bujor A, Castelino F, Chung L, Evnin L, Frech T, Gordon J, Griffith M, Hant F, Harding M, Hummers L, Khanna D, Lakin K, Lebiedz-Odrobina D, Luo Y, Makol A, Mayes M, McMahan Z, Molitor J, Moore D, Paik J, Richardson C, Skaug B, Shah A, Shah A, Steen V, VanBuren J, Volkmann E, Zahn C, Sandorfi N. Arthritis Care and Research, 2026 May 13;Journal ArticleDiscordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
-
Massay R, Zahn C, Tsou PS. Current Opinion in Rheumatology, 2026 Jan 7; 37 (6): 373 - 383.Journal ArticleDecoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications
DOI:10.1097/BOR.0000000000001126 -
Massay R, Zahn C, Tsou PS. Current Opinion in Rheumatology, 2026 Jan 7; 37 (6): 373 - 383.Journal ArticleDecoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications
DOI:10.1097/BOR.0000000000001126 -
Ayla AY, Bernstein EJ, Zhang M, VanBuren JM, Castelino FV, Chung L, Evnin L, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Mayes M, McMahan ZH, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Skaug B, Steen VD, Volkmann ER, Zahn C, Zheng WJ, Assassi S. J Rheumatol, 2025 Nov 15;Journal ArticleType III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
DOI:10.3899/jrheum.2025-0532 PMID: 41241390 -
Zahn C. 2025 Oct 15;PresentationRaynaud’s and Why it Matters in Systemic Sclerosis
-
Jamali M, Kaur A, Huang S, St. Clair J, Varga J, Zahn C, Mulcaire-Jones E, Lescoat A, Khanna D. 2025 Oct 25;Proceeding / Abstract / PosterAutoantibody Profiles and Disease Trajectories in Early Systemic Sclerosis: Insights from a Prospective Cohort
-
Romich E, Ogdie A, Stephens Shields A, et al , Zahn C, et al . 2025 Oct 25;Proceeding / Abstract / PosterDiscordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis